This is a limited company view. Sign up for a Free Trial to see everything.

VIRIDAXIS is a Belgian biotechnology company specialized in the mass production of parasitoids to control aphids.

B2B
Biotechnology
Healthcare
Household & Personal Products
Personal Products
Pharmaceuticals

Overview

Location

Gosselies

Founded

2004

Employees

13

Stage

Series B

Total funding

$1M

Last funding

10 years ago

Acquisitions

0

Growth score

17

Mindshare score

8

Scoring

Deals

$1.4M Series B

Sopartec, SRIW

Oct 22, 2007

Employee Growth

Use VIRIDAXIS's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use VIRIDAXIS's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Ouvrier production
technicienne de production
assistant de production
Technicien de production
Technicien de Production
Scientist Life Sciences - ingénieur recherche R&D
Production
Assistant de production
Directrice logistique et formation

Similar Companies

KannaLife Sciences

KannaLife Sciences, Inc. is a bio-pharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. KannaLife Sciences currently holds an exclusive license with National Institutes of Health - Office of Technology Transfer (NIH-OTT) for the Commercialization of U.S. Patent 6,630,507, Cannabinoids as Antioxidants and Neuroprotectants (the 507 Patent). KannaLife is currently conducting research and development at the Bucks County Biotechnology Center in Doylestown, PA, for a target drug candidate to treat Hepatic Encephalopathy (HE). HE is an oxidative stress related disease that affects the cognitive and behavioral functions, and the wellness of the brain. #6630507, 6630507
Series A

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes